Shine-On BioMedical Co (ROCO:6926) FCF Margin %: -102.52% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6926 Shine-On BioMedical Co Ltd ROCO:6926
12 GF Score
Price NT$64.80
! 1 Warning Sign
View Full Analysis

What is Shine-On BioMedical Co FCF Margin %?

Shine-On BioMedical Co ROCO:6926 12 FCF Margin % is -102.52% as of Dec. 2025. GuruFocus rates ROCO:6926 with a GF Score™ of 12/100. The stock has 1 warning sign investors should review. Among 950 Biotechnology companies, Shine-On BioMedical Co ranks worse than 68.32% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Shine-On BioMedical Co's Free Cash Flow for the six months ended in Dec. 2025 was NT$-30.76 Mil. Shine-On BioMedical Co's Revenue for the six months ended in Dec. 2025 was NT$30.00 Mil. Therefore, Shine-On BioMedical Co's FCF Margin % for the quarter that ended in Dec. 2025 was -102.52%.

As of today, Shine-On BioMedical Co's current FCF Yield % is -3.59%.

The historical rank and industry rank for Shine-On BioMedical Co's FCF Margin % or its related term are showing as below:

ROCO:6926' s FCF Margin % Range Over the Past 10 Years
Min: -385.95   Med: -337.56   Max: -289.17
Current: -385.95

During the past 7 years, the highest FCF Margin % of Shine-On BioMedical Co was -289.17%. The lowest was -385.95%. And the median was -337.56%.

ROCO:6926's FCF Margin % is ranked worse than
68.32% of 950 companies
in the Biotechnology industry
Industry Median: -81.28 vs ROCO:6926: -385.95

Shine-On BioMedical Co FCF Margin % Related Terms

Shine-On BioMedical Co FCF Margin % Historical Data

* Premium members only.

The historical data trend for Shine-On BioMedical Co's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shine-On BioMedical Co FCF Margin % Chart

Shine-On BioMedical Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial 0.00 0.00 -289.17 0.00 -385.95

Shine-On BioMedical Co Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -178.30 0.00 0.00 0.00 -102.52

ROCO:6926 vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Shine-On BioMedical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shine-On BioMedical Co FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shine-On BioMedical Co's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Shine-On BioMedical Co's FCF Margin % falls into.


ROCO:6926
12GF Score
Shine-On BioMedical Co Ltd ROCO:6926
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shine-On BioMedical Co FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Shine-On BioMedical Co's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-115.785/30
=-385.95 %

Shine-On BioMedical Co's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-30.755/30
=-102.52 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -102.52% mean?
Shine-On BioMedical Co (ROCO:6926) has a FCF Margin % of -102.52% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shine-On BioMedical Co and its competitors. According to the industry distribution chart, Shine-On BioMedical Co ranks #649 out of 950 companies in the Biotechnology industry, placing it in the top 68.3%.
Is Shine-On BioMedical Co's FCF Margin % too high?
Shine-On BioMedical Co's current FCF Margin % is -102.52%. Based on the distribution chart, Shine-On BioMedical Co ranks #649 out of 950 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Shine-On BioMedical Co has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Shine-On BioMedical Co's FCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shine-On BioMedical Co ranks #649 out of 950 companies for FCF Margin %. This places Shine-On BioMedical Co in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Shine-On BioMedical Co and its competitors. Shine-On BioMedical Co's current FCF Margin % is -102.52%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shine-On BioMedical Co stock overvalued right now?
Shine-On BioMedical Co (ROCO:6926) has a current FCF Margin % of -102.52%. The current FCF Margin % is -102.52%. Shine-On BioMedical Co's overall GF Score™ is 12/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Shine-On BioMedical Co (ROCO:6926), the current FCF Margin % is -102.52% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shine-On BioMedical Co Business Description

Address No. 573, Taiwan Boulevard, 10th Floor, Section 2, West District, Taichung, TWN
Shine-On BioMedical Co Ltd develops drugs based on antibodies and nucleic acids. The Company researches, develops, manufactures, and distributes antibody anticancer drugs, nucleic acid anticancer drugs. The company's drug development and nucleic acid therapeutics are focused on providing patients with effective cancer treatment options.
12GF Score

Get the complete analysis for ROCO:6926

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$64.80
Price